The cybersecurity software provider has now secured $85m in total, having pulled in series B funding from investors including Siemens' Next47 unit.

Main Sequence Ventures has returned for a $47m round, having previously co-led a $13.7m series B for the satellite launch technology producer.

SBCVC helped supply $46.5m for smart industrial software developer Ones while e-commerce marketplace aggregator 10club raised $40m in a PDC and HeyDay-backed seed round.

The Bitmain-backed blockchain software developer is looking to launch a cryptocurrency exchange platform with $49m of funding from Cryptology Asset Group.

Gree's GFR Fund helped the virtual reality platform close a series D round which will support expansion and the development of new features including a creator economy.

Taikang Insurance Group’s asset management arm has co-led the second tranche of an $83m round for the autism and speech therapy provider.

Third Rock Ventures has led a series A round for Abata Therapeutics that also featured fellow existing investor ElevateBio.

Third Rock Ventures has led a series A round for Abata Therapeutics, launched by the firm to commercialise research from Harvard, MIT, Johns Hopkins, NIH and UZH.

Gilead Sciences, Yipinhong Pharmaceutical and Mass General Brigham Ventures helped the slow-release drug developer secure series C cash bringing its overall funding to almost $250m.

GV participated in a series C round for the fertility and gynaecology services provider at a $612m valuation, doubling its overall funding.